Back
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
75
HIBL
Direxion Daily S&P 500® Hi Bt Bl 3X ETF
Last Price:
44.94
Seasonality Move:
62.84%
Sell
37
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
58.90
Seasonality Move:
13.85%
Buy
75
Direxion Daily S&P 500® Hi Bt Bl 3X ETF (HIBL)
is a Buy
Is Direxion Daily S&P 500® Hi Bt Bl 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P 500® Hi Bt Bl 3X ETF [HIBL] share price is $44.99. The Score for HIBL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- HIBL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $58.97. The Score for BIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HIBL Stock Price Chart
What is Direxion Daily S&P 500® Hi Bt Bl 3X ETF's stock price today?
-
The Direxion Daily S&P 500® Hi Bt Bl 3X ETF share price today is $44.99
The current trend is moderately bearish and HIBL is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $58.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
HIBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 49.47 | Sell |
| Chaikin Money Flow: | -21166 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 36.87 | Sell |
| Chaikin Money Flow: | -16746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.4 - 65.18) | Sell |
| Bollinger Bands (100): | (61.11 - 66.65) | Sell |
HIBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.73 | Sell |
| 20-day SMA: | 45.19 | Sell |
| 50-day SMA: | 43.76 | Buy |
| 200-day SMA: | 42.26 | Buy |
| 8-day EMA: | 46.13 | Sell |
| 20-day EMA: | 45.5 | Sell |
| 50-day EMA: | 44.15 | Buy |
| 200-day EMA: | 41.29 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.76 | Sell |
| 20-day SMA: | 62.96 | Sell |
| 50-day SMA: | 63.65 | Sell |
| 200-day SMA: | 60 | Sell |
| 8-day EMA: | 62.64 | Sell |
| 20-day EMA: | 63.06 | Sell |
| 50-day EMA: | 63.36 | Sell |
| 200-day EMA: | 60.49 | Sell |
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Earnings Growth & HIBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||